Clinical Trials Logo

Depression Chronic clinical trials

View clinical trials related to Depression Chronic.

Filter by:
  • None
  • Page 1

NCT ID: NCT04211467 Recruiting - Depression Clinical Trials

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression

Start date: March 2, 2020
Phase:
Study type: Observational

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records

NCT ID: NCT04159285 Completed - Clinical trials for Treatment Resistant Depression

Psychotherapeutic Augmentation of Brain Stimulation Effects

PAUSE
Start date: January 5, 2019
Phase: N/A
Study type: Interventional

This study aims to investigate effectiveness and feasability of a 15-week group psychotherapeutic intervention as continuation treatment after electroconvulsive therapy in severely depressed patients. Feasibility and acceptance of the half-open manualized CBT intervention are assessed. Depressive symptoms, quality of life and emotion regulation skills will be assessed before ECT treatment, before and after the 15-week group CBT intervention and at a 6 months follow-up after treatment end and compared to depressed patients treated with ECT who did not partake in group CBT. Moreover, patients will attend two indidivual pre-group sessions with one of the group therapist and one individual post-group session

NCT ID: NCT03904342 Withdrawn - Anxiety Clinical Trials

Sophie Pilot Implementation and Assessment

Start date: January 2021
Phase: N/A
Study type: Interventional

Evidence-based interventions using cognitive behavioral therapy (CBT) and self-management education have been demonstrated to effectively treat symptoms of depression and improve the quality of life in populations with chronic illness. Research indicates that CBT is the most effective psychosocial treatment for depression; as effective as pharmacotherapy and as effective as adding another medication for patients who do not respond to one antidepressant alone. Despite the existence of proven efficacious treatments for depression, however, fewer than half of patients for whom depression treatment is indicated receive the services they need. Access barriers (i.e., transportation, insurance coverage), limited clinician availability (i.e., long waitlists, difficulty finding a provider), and competing (and time-consuming) medical priorities contribute to inadequate depression treatment for individuals with serious chronic illness. In this research the investigators will conduct a pilot randomized trial to compare results from implementation of two CBT strategies iHope and Sophie.